Product Code: ETC066703 | Publication Date: Jun 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
India infectious disease point-of-care testing market is projected to reach USD 707.7 million by 2029, growing at a CAGR of 12.3% from 2020 to 2029. This growth can be attributed to the increasing prevalence and incidence of various infectious diseases such as HIV, malaria, cholera, Dengue fever and leptospirosis in India; increased government initiatives for the diagnosis & treatment of infectious diseases; technological advancements in diagnostics; availability of rapid test kits; rising demand for personalized medicine and reducing time required for results due to automation in tests are expected to drive the growth of Indian Infectious Disease Point-of Care Testing Market over the forecast period (2023?2029).
However, high cost associated with point-of care testing devices along with lack of awareness regarding infection control among health practitioners may restrain the market growth during this period.
The introduction of new optical or electrochemical immunosensors based on fluorescence technology has opened up a range of possibilities within point-of care testing applications that will help bring significant changes in how infections are managed globally including India. Moreover, companies like Abbott Laboratories, Danaher Corporation and Roche Diagnostics have invested heavily into R&D activities related to diagnostic tests used for detecting common illnesses such as COVID 19 pandemic which has resulted into availability & affordability thereby fostering industry trends towards adoption & usage in India leading it towards an anticipated robust growth over forecast timeline (2020 ? 2026).
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Infectious Disease Point-of-care Testing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Infectious Disease Point-of-care Testing Market Revenues & Volume, 2020 & 2027F |
3.3 India Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 India Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 India Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2020 & 2027F |
3.6 India Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2020 & 2027F |
3.7 India Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2020 & 2027F |
4 India Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Infectious Disease Point-of-care Testing Market Trends |
6 India Infectious Disease Point-of-care Testing Market, By Types |
6.1 India Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2018 - 2027F |
6.1.3 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2018 - 2027F |
6.1.4 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2018 - 2027F |
6.1.5 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2018 - 2027F |
6.1.6 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2018 - 2027F |
6.1.7 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 India Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2018 - 2027F |
6.2.3 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2018 - 2027F |
6.2.4 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2018 - 2027F |
6.2.5 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2018 - 2027F |
6.3 India Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2018 - 2027F |
6.3.3 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2018 - 2027F |
6.3.4 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2018 - 2027F |
6.3.5 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2018 - 2027F |
7 India Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 India Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 India Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 India Infectious Disease Point-of-care Testing Market Key Performance Indicators |
9 India Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 India Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2020 & 2027F |
9.2 India Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2020 & 2027F |
9.3 India Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2020 & 2027F |
10 India Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 India Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2020 |
10.2 India Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |